Ovarian cancer is one of the most common malignancies in women and contributes greatly to cancer-related deaths. Tumor suppressor candidate 3 (TUSC3) is a putative tumor suppressor gene located at chromosomal region 8p22, which is often lost in epithelial cancers. Epigenetic silencing of TUSC3 has been associated with poor prognosis, and hypermethylation of its promoter provides an independent biomarker of overall and disease-free survival in ovarian cancer patients. TUSC3 is localized to the endoplasmic reticulum in an oligosaccharyl tranferase complex responsible for the N-glycosylation of proteins. However, the precise molecular role of TUSC3 in ovarian cancer remains unclear. In this study, we establish TUSC3 as a novel ovarian cancer tumor suppressor using a xenograft mouse model and demonstrate that loss of TUSC3 alters the molecular response to endoplasmic reticulum stress and induces hallmarks of the epithelial-to-mesenchymal transition in ovarian cancer cells. In summary, we have confirmed the tumor-suppressive function of TUSC3 and identified the possible mechanism driving TUSC3-deficient ovarian cancer cells toward a malignant phenotype.Ovarian cancer (OC) is one of the most common malignancies and the fifth leading cause of cancer-related death in women.1 Despite the recent progress in OC diagnosis and therapy, its overall prognosis remains unfavorable. The heterogeneity of its clinical display reflects the diverse molecular mechanisms contributing to malignant transformation and dissemination of the primary cancer. The tumor suppressor candidate 3 (TUSC3 or N33) gene has been located to chromosomal region 8p22, which is often lost in common epithelial cancers, such as breast, prostate, oral squamous or ovarian cancer. [2][3][4][5][6] According to the Oncomine database, expression of TUSC3 gene is significantly downregulated in OC cases, suggesting the potential clinical relevance of TUSC3 in OC pathogenesis (www.oncomine.org, Supporting Information Fig. 1). Moreover, epigenetic silencing of TUSC3 has been associated with poor prognosis of OC, and hypermethylation of its promoter provides an independent biomarker of overall and disease-free survival in OC patients. 7 Until recently, the molecular function of TUSC3 was inferred from its sequence homology to the yeast protein Ost3p, which forms a subunit of the oligosaccharyltransferase (OST) complex that is responsible for post-and co-translational N-glycosylation of proteins in the endoplasmic reticulum (ER). 8 We demonstrated recently that in embryonic kidney (HEK293) and ovarian cancer cells, TUSC3 localizes to the